tldrdailynews.com logo

Generic antidepressant recall due to nitrosamine cancer risk

1 min read
Source: NBC New York
Generic antidepressant recall due to nitrosamine cancer risk
Photo: NBC New York
TL;DR

Breckenridge Pharmaceuticals recalled certain lots of duloxetine (generic Cymbalta) after FDA testing found nitrosamine levels above the agency’s limit, affecting 30 mg (exp. Apr 2027, Lot 241180C) and two 60 mg lots (Feb 2026 Lot 230286C; Feb 2027 Lot 24072lC). Patients should contact their doctor or pharmacist and not stop taking the medication without medical guidance.

Topics:businesshealth#cancer-risk#duloxetine#fda#health#nitrosamines#recall
Share this article
  1. Popular antidepressant recalled over high levels of a cancer-causing compound  NBC New York
  2. Nearly 375,000 bottles of antidepressant recalled over cancer-linked impurity  Houston Chronicle
  3. Nearly 375,000 bottles of popular antidepressant recalled over high levels of carcinogen  KVUE
  4. Antidepressant recalled due to presence of potentially cancer-causing impurity  ABC News - Breaking News, Latest News and Videos
  5. FDA Announces Recall of Popular Antidepressant Over Possible Carcinogen Risk  Health: Trusted and Empathetic Health and Wellness Information

Want the full story? Read the original reporting

Read on NBC New York